Clinical Trial Update: Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab with chemotherapy and radiation for operable stage III or IV head and neck cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-03-11